Paediatric Strongyloidiasis in Central Australia.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Locally acquired strongyloidiasis in remote Australia: why are there still cases?Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
   Review
2. The Association between Diabetes and Human T-Cell Leukaemia Virus Type-1 (HTLV-1) withInternational journal of environmental research and public health · 2022
   Article
3. Zoonoses and the Aboriginal and Torres Strait Islander population: A One Health scoping review.PLOS global public health · 2022
   Article
4. Advances in the Molecular and Cellular Biology ofCurrent tropical medicine reports · 2019
   Article
5. Control of Communicable Diseases in Human and in Animal Populations: 70th Anniversary of the Year of the Birth of Professor Rick Speare (2 August 1947⁻5 June 2016).Tropical medicine and infectious disease · 2018
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as